PFIZER INC. for PFIZER INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2012 | $3,540,000 | Replaced |
| 1st Quarter - Amendment | May 25, 2012 | $3,550,000 | Yes |
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Repatriation Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax Reform Territorial Systems Patent/Innovation Box H.R. 2735, CFC Look Through Permanency H.R. 1834, Freedom to Invest Act H.R. 2495, Tax Equity and Middle Class Fairness Act (excess returns) H.R. 2280, The Offshoring Prevention Act S. 1671, The Foreign Earnings Reinvestment Act S. 1346, The Stop Tax Haven Abuse Act S. 45, The Offshoring Prevention Act S. 1813, Moving Ahead for Progress in the 21st Century Act "Highway Bill"
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEN W COLE | — |
| CAROLINE MOODY SCHELLHAS | — |
Health Issues HCR
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEN W COLE | — |
| JOHN PAUL HALLIWELL | — |
| LOUIS A LAMARCA | — |
| ANGELA WALKER RIEMER | — |
| MARY BRIDGET WALSH | — |
| JENNIFER SWENSON WALTON | — |
Consumer Issues/Safety/Products CSP
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account Supply Chain Issues Counterfeits
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEN W COLE | — |
| JOHN PAUL HALLIWELL | — |
| MARY BRIDGET WALSH | — |
| JENNIFER SWENSON WALTON | — |
Defense DEF
Homeland Security and Defense Issues Surrounding Readiness for a Chemical Nerve Agent Attack or Industrial Accident.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARY BRIDGET WALSH | — |
Alcohol and Drug Abuse ALC
Opioid Abuse Priscription Drug Abuse
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER DUCK | — |
| JOHN PAUL HALLIWELL | — |
| ANGELA WALKER RIEMER | — |
Copyright/Patent/Trademark CPT
Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEN W COLE | — |
| JOHN PAUL HALLIWELL | — |
| ANGELA WALKER RIEMER | — |
| MARY BRIDGET WALSH | — |
| JENNIFER SWENSON WALTON | — |
Medicare/Medicaid MMM
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEN W COLE | — |
| JOHN PAUL HALLIWELL | — |
| ANGELA WALKER RIEMER | — |
| MARY BRIDGET WALSH | — |
| JENNIFER SWENSON WALTON | — |
Trade (domestic/foreign) TRD
Trans Pacific Partnership Negotiations
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN PAUL HALLIWELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.